### Bruker Corporation Reports Q2 2024 Financial Results

### Bruker Corporation Reports Q2 2024 Financial Results Bruker Corporation (NASDAQ: BRKR) announced its financial results for the second quarter (Q2) and the first half of the fiscal year 2024, ending June 30, 2024. #### Key Financial Metrics | Metric | Q2 2023 | Q2 2024 | Year-over-Year Change | Consensus Estimates | |--------|---------|---------|-----------------------|---------------------| | Total Revenue | $681.9M | $800.7M | +17.4% | $796.54M | | GAAP EPS | $0.39 | $0.05 | -87.2% | N/A | | Non-GAAP EPS | $0.50 | $0.52 | +4.0% | $0.52 | Bruker reported strong total revenue growth in Q2 2024 of 17.4% year-over-year, slightly above Wall Street consensus estimates. The company's non-GAAP EPS met consensus expectations, increasing by 4.0% from the previous year. However, GAAP EPS saw a significant decline, which points towards higher operational or one-time costs. #### Segment Performance | Segment | Q2 2023 Revenue | Q2 2024 Revenue | Year-over-Year Change | |---------|-----------------|-----------------|-----------------------| | Bruker Scientific Instruments (BSI) | $614.3M | $735.6M | +19.7% | | Bruker Energy & Supercon Technologies (BEST) | $72.7M | $69.1M | -5.0% | The Bruker Scientific Instruments (BSI) segment saw robust growth of 19.7%, while the Bruker Energy & Supercon Technologies (BEST) segment experienced a decline of 5.0%. The underperformance in the BEST segment contrasts with the substantial growth seen in BSI, which was primarily driven by Bruker's innovation and strategic acquisitions. #### Operational Data | Metric | Q2 2023 | Q2 2024 | Change | |--------|---------|---------|--------| | GAAP Operating Income | $86.2M | $48.1M | -44.2% | | Non-GAAP Operating Income | $104.1M | $110.7M | +6.3% | | Non-GAAP Operating Margin | 15.3% | 13.8% | -150 basis points | #### Executive Comments Frank H. Laukien, President and CEO, commented on the excellent revenue growth achieved despite challenging market conditions, attributing success to Bruker's differentiated innovation and strategic acquisitions. He emphasized that the company is well-positioned for continued margin expansion and rapid EPS growth. #### Forward Guidance Bruker has increased its FY 2024 revenue guidance to $3.38-$3.44 billion, factoring in the NanoString acquisition. This implies year-over-year revenue growth of 14% to 16%. The company also updated its non-GAAP EPS guidance to $2.59-$2.64 for FY 2024. #### Stock Price Movement Following the earnings release, Bruker's stock price saw a decrease of -3.55%. In summary, Bruker Corporation has demonstrated strong revenue performance across its primary segments and reaffirmed its growth trajectory through strategic acquisitions and innovation. Despite challenges reflected in GAAP metrics, the company's adjusted figures show positive trends. The forward guidance reflects confidence in continuing growth, albeit the market reacted negatively post-announcement. --- The report has been organized into a clear and concise format suitable for investors.